USP7 reduces the level of nuclear DICER, impairing DNA damage response and promoting cancer progression
-
Published:2023-11-02
Issue:1
Volume:18
Page:170-189
-
ISSN:1574-7891
-
Container-title:Molecular Oncology
-
language:en
-
Short-container-title:Molecular Oncology
Author:
Liu Xiaojia1,
Lu Runhui1,
Yang Qianqian1,
He Jianfeng1,
Huang Caihu1,
Cao Yingting1,
Zhou Zihan1,
Huang Jiayi1,
Li Lian1,
Chen Ran1,
Wang Yanli1,
Huang Jian1,
Xie Ruiyu2ORCID,
Zhao Xian1ORCID,
Yu Jianxiu1ORCID
Affiliation:
1. Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation Shanghai Jiao Tong University School of Medicine China
2. Department of Biomedical Sciences, Faculty of Health Sciences University of Macau China
Abstract
Endoribonuclease DICER is an RNase III enzyme that mainly processes microRNAs in the cytoplasm but also participates in nuclear functions such as chromatin remodelling, epigenetic modification and DNA damage repair. The expression of nuclear DICER is low in most human cancers, suggesting a tight regulation mechanism that is not well understood. Here, we found that ubiquitin carboxyl‐terminal hydrolase 7 (USP7), a deubiquitinase, bounded to DICER and reduced its nuclear protein level by promoting its ubiquitination and degradation through MDM2, a newly identified E3 ubiquitin‐protein ligase for DICER. This USP7‐MDM2‐DICER axis impaired histone γ‐H2AX signalling and the recruitment of DNA damage response (DDR) factors, possibly by influencing the processing of small DDR noncoding RNAs. We also showed that this negative regulation of DICER by USP7 via MDM2 was relevant to human tumours using cellular and clinical data. Our findings revealed a new way to understand the role of DICER in malignant tumour development and may offer new insights into the diagnosis, treatment and prognosis of cancers.
Funder
National Key Research and Development Program of China
National Natural Science Foundation of China
Natural Science Foundation of Shanghai Municipality
Subject
Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献